Journal
GENE THERAPY
Volume 19, Issue 12, Pages 1141-1149Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/gt.2011.204
Keywords
protein therapy; apoptosis; cochlea; aminoglycoside; topical application
Categories
Funding
- Ministry of Education, Culture, Sports, Science, and Technology of Japan [17659527, 20390440]
- Ministry of Health, Labor and Welfare of Japan [15110201]
- Grants-in-Aid for Scientific Research [23300257, 17659527, 20390440, 24651055, 23390393] Funding Source: KAKEN
Ask authors/readers for more resources
We previously demonstrated that an artificial protein, TAT-FNK, has antiapoptotic effects against cochlear hair cell (HC) damage caused by ototoxic agents when applied systemically. To examine the feasibility of topical protein therapy for inner ear disorders, we investigated whether gelatin sponge soaked with TAT-FNK and placed on the guinea pig round window membrane (RWM) could deliver the protein to the cochlea and attenuate aminoglycoside (AG)-induced cochlear damage in vivo. First, we found that the immunoreactivity of TAT-myc-FNK was distributed throughout the cochlea. The immunoreactivity was observed from 1-24 h after application. When Tat-FNK was applied 1 h before ototoxic insult (a combination of kanamycin sulfate and ethacrynic acid), auditory brainstem response threshold shifts and the extent of HC death were significantly attenuated. When cochlear organotypic cultures prepared from P5 rats were treated with kanamycin, TAT-FNK significantly reduced the extent of caspase-9 activation and HC death. These findings indicate that TAT-FNK topically applied on the RWM can enter the cochlea by diffusion and effectively prevent AG-induced apoptosis of cochlear HCs by suppressing the mitochondrial caspase-9 pathway. Gene Therapy (2012) 19, 1141-1149; doi: 10.1038/gt.2011.204; published online 22 December 2011
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available